Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment
NCT06674915
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Complement Mediated Primary or Secondary Glomerular Diseases
Interventions
DRUG:
HRS-5965 capsules
Sponsor
Chengdu Suncadia Medicine Co., Ltd.